BPG is committed to discovery and dissemination of knowledge
Welcome to the World Journal of Clinical Oncology

The World Journal of Clinical Oncology (WJCO) is a leading academic journal devoted to reporting the latest, cutting-edge research progress and findings of basic research and clinical practice in the field of oncology.  It was launched on November 10, 2010 and is published bimonthly (6 issues annually) by BPG, the world's leading professional clinical medical journal publishing company.

We encourage oncologists worldwide to submit manuscripts to the WJCO describing their original basic or clinical research findings that are of high academic value and which report new diagnostic techniques or summarize their treatment experiences.

The usual times related to all publication processes of the WJCO are as follows: (1) From manuscript receipt to peer-review: 2-4 weeks; (2) From initial manuscript acceptance, with revisions, to return of the revised manuscript from the authors: 4-5 weeks; (3) From return of the revised manuscript from the authors to final acceptance: 1-2 weeks; (4) From final acceptance to an article in press: 2 days; and (5) From article in press designation to formal release of the electronic version and all online documentation: 2-9 weeks. The WJCO’s acceptance rate: 55%. Submit here >>

2018 Published Issues
5 4 3 2 1
WJCO is now abstracted and indexed in PubMed, PubMed Central, Scopus, and Emerging Sources Citation Index (Web of Science), China National Knowledge Infrastructure (CNKI), and Superstar Journals Database.
Journal Metrics
IPP (Impact per Publication) (2015): 3.306; SNIP (Source Normalized Impact per Paper) (2015): 1.241; CiteScore (2016): 4.00.
2218-4333 (online)
Cancer prevention in patients with human immunodeficiency virus infection 
Evripidis Valanikas, Konstantinos Dinas, Konstantinos Tziomalos 
World J Clin Oncol 9(5):71-73. Published online Sep 14, 2018. doi: 10.5306/wjco.v9.i5.71
Oxytocin and cancer: An emerging link 
Ben Lerman, Trisheena Harricharran, Olorunseun O Ogunwobi 
World J Clin Oncol 9(5):74-82. Published online Sep 14, 2018. doi: 10.5306/wjco.v9.i5.74
Role of polymorphisms in genes that encode cytokines and Helicobacter pylori virulence factors in gastric carcinogenesis 
Breno Bittencourt de Brito, Filipe Antônio França da Silva, Fabrício Freire de Melo 
World J Clin Oncol 9(5):83-89. Published online Sep 14, 2018. doi: 10.5306/wjco.v9.i5.83
Resistance to FLT3 inhibitors in acute myeloid leukemia: Molecular mechanisms and resensitizing strategies 
Jianbiao Zhou, Wee-Joo Chng 
World J Clin Oncol 9(5):90-97. Published online Sep 14, 2018. doi: 10.5306/wjco.v9.i5.90
Basic Study
Tunable structure priors for Bayesian rule learning for knowledge integrated biomarker discovery 
Jeya Balaji Balasubramanian, Vanathi Gopalakrishnan 
World J Clin Oncol 9(5):98-109. Published online Sep 14, 2018. doi: 10.5306/wjco.v9.i5.98
Retrospective Study
FOLFIRI3-aflibercept in previously treated patients with metastatic colorectal cancer 
Candice Carola, François Ghiringhelli, Stefano Kim, Thierry André, Juliette Barlet, Leïla Bengrine-Lefevre, Hélène Marijon, Marie-Line Garcia-Larnicol, Christophe Borg, Linda Dainese, Nils Steuer, Hubert Richa, Magdalena Benetkiewicz, Annette K Larsen, Aimery de Gramont, Benoist Chibaudel 
World J Clin Oncol 9(5):110-118. Published online Sep 14, 2018. doi: 10.5306/wjco.v9.i5.110